Month: April 2020

All amounts expressed in US dollarsDAR ES SALAAM, Tanzania, April 08, 2020 (GLOBE NEWSWIRE) — Twiga Minerals Corporation, a joint venture between Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) and the Tanzanian government, has announced a support program to assist the country in combating and containing the Covid-19 pandemic.Barrick’s chief operating officer for its Africa and Middle East region, Willem Jacobs, said in addition to measures already introduced to protect workers and their families living and around its mines, the company was contributing $1.7 million in the form of critical equipment and expertise to help prevent the spread of the virus in Tanzania.Of this amount, $960,000 is destined for the national level, $505,000 to the regional level and $250,000 to the local level.Jacobs said at the national level Barrick would...

Aðalfundur Landsbankans hf. verður haldinn miðvikudaginn 22. apríl 2020 kl. 13:00. Fundurinn verður haldinn í Austurstræti 11, Reykjavík.Hjálögð er dagskrá aðalfundar.Nánari upplýsingar veita:Hanna K. Thoroddsen, fjárfestatengsl, ir@landsbankinn.isRúnar Pálmason, upplýsingafulltrúi, samskipti@landsbankinn.is ViðhengiAðalfundur Landsbankans 2020 dagskrá

The Annual General Meeting of Landsbankinn hf. will be held on Wednesday 22 April 2020 at 13:00. The meeting will be held at Austurstræti 11, Reykjavík.Enclosed is the agenda for the Annual General Meeting.For further information:Hanna K. Thoroddsen, Investor Relations, ir@landsbankinn.isRúnar Pálmason, Public Relations, pr@landsbankinn.is   AttachmentAGM Landsbankinn 2020 agenda

BETHLEHEM, Pa., April 08, 2020 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the appointment of David J. Shulkin, M.D., as a member of the Company’s Board of Directors.  Dr. Shulkin, a former Secretary of the U.S. Department of Veterans Affairs, will serve as a Class I Director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.  He will also serve on the Audit Committee and the Nominating and Corporate Governance Committee of the Board.“We are very pleased that David has agreed to serve on our Board of Directors,” said Stephen S. Tang, Ph.D., President and Chief Executive Officer of OraSure Technologies. “David has had a long and distinguished...

BETHESDA, Md., April 08, 2020 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, today announced that it will host a teleconference call for the financial community on April 23, 2020 at 10:00 a.m. (ET) to discuss its first quarter 2020 financial results.  Those results will be released after the close of business on April 22, 2020.Interested parties may call 1.877.303.6220 to listen and participate in the call.  The Conference ID Code is 2947417. The call will also be available live via webcast on the Company’s website which is www.EagleBankCorp.com.  A replay of the call will be available on the Company’s website through May 7, 2020.Caution About Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Securities Exchange Act of...

MONTRÉAL, April 08, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELXIF) (FRA 2QLA) (“ELIXXER” or (the “Company”) is pleased to announce that its pharmaceutical partner, Freia launches production of ImmunoV Forte, to improve and protect respiratory function in the human body against airborne infections.   Freia is initiating clinical trials on the active ingredients in ImmunoV Forte that aid and protect the human respiratory tract from external environmental attacks such as respiratory viruses, bacteria, smoke and pollution.  In being compliant with Canadian Exchange regualators, both Elixxer and Freia are not making any expressed or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.  Post trials the company will update the market as to...

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — Teranga Gold Corporation (“Teranga” or the “Company”) (TSX:TGZ; OTCQX:TGCDF) today announced the appointment of Simon Bottoms, MGeol, FGS CGeol, FAusIMM, to the Company’s board of directors, effective immediately. Mr. Bottoms was nominated to join Teranga’s board of directors by Barrick Gold Corporation (“Barrick”), the Company’s second largest shareholder.  Pursuant to the terms of an investor agreement related to the Company’s recent acquisition of the Massawa gold project, Barrick is entitled to nominate one board member so long as it retains at least a 10% ownership interest in Teranga.Mr. Bottoms is currently Senior Vice President Africa & Middle East Mineral Resource Manager for Barrick, where he is responsible for the management of all Africa and Middle East mine operations...

Safety of personnel, patients and healthcare providers remains our top priority Drug supply remains well-stocked with patients having access to uninterrupted supply of Firdapse® (amifampridine) 10mg Catalyst partners with First Responders Children’s Foundation to support COVID-19 EMERGENCY RESPONSE FUNDCORAL GABLES, Fla., April 08, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today provided an update on certain impacts of COVID-19 on its business operations.“We are committed to protecting the safety and well-being of our personnel, the entire LEMS community, healthcare providers, patients in clinical trials,...

HONOLULU, April 08, 2020 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) (the “Company”) today announced that the NYSE American LLC (the “Exchange”) has accepted the Company’s plan of compliance (the “Plan”) for continued listing on the Exchange.As previously reported, on January 13, 2020, the Company received a letter from NYSE American Staff indicating that the Company is not in compliance with certain continued listing standards relating to stockholders equity as set forth in Part 10, Section 1003 of the NYSE American Company Guide (the “Guide”). Based on the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2019, which was filed with the Securities and Exchange Commission (SEC) on December 20, 2019, the Company was below compliance with Part 10, Sections 1003(a)(i) and (a)(ii) of...

NVX-CoV2373 identified as SARS-CoV-2 candidate for Phase 1 clinical trialIn preclinical studies, NVX-CoV2373 demonstrated high immunogenicity and stimulated high levels of neutralizing antibodiesFirst-in-human Phase 1 clinical trial accelerated to mid-May with preliminary results in JulyGMP clinical production initiated at Emergent BioSolutions with ability to leverage capacity for large scale manufacturingGAITHERSBURG, Md., April 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate a first-in-human trial in mid-May. Novavax’ proprietary Matrix-M™...